Results 121 to 130 of about 359,727 (267)

The Ryan Medicare Plan: Winners and Losers [PDF]

open access: yes
Representative Paul Ryan's proposed 2012 budget has been lauded as a path to prosperity, with much attetion given to his overhaul of the medicare system. Using data from the CBO analysis of the Ryan plan, this issue brief demonstrates that any savings to
David Rosnick, Dean Baker
core  

A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Immediate lymphatic reconstruction (ILR) performed to prevent breast cancer related lymphedema is not consistently covered by insurance payors in the United States. Methods Retrospective review was performed on a prospective database of ILR candidates from 2018 to 2022.
Anne Huang   +4 more
wiley   +1 more source

Representative Ryan’s $30 Trillion Medicare Waste Tax [PDF]

open access: yes
Representative Ryan’s proposal to replace the current Medicare systemwith a system of vouchers or premium supports has been widely described as shifting costs from the government to beneficiaries.
David Rosnick, Dean Baker
core  

Trends in Immunotherapy (IO) Use and Survival Among Patients With High‐Incidence Stage IV Cancers Across the United States

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives IO has transformed cancer management, but its adoption in advanced cancer patients varies by tumor type. With more Stage IV patients undergoing surgery, understanding site‐specific outcomes in these challenging patients is essential.
Samantha C. Warwar   +4 more
wiley   +1 more source

Sequence of Chemotherapy May Not Impact Survival After Resection of Pancreatic Tail Adenocarcinoma

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Introduction Pancreatic ductal adenocarcinoma (PDAC) of the body/tail is notably different than PDAC in the head of the pancreas. Surgery plus chemotherapy is known to improve outcomes for all PDAC. The sequence of this therapy is well studied in head cancers yet has never been evaluated systematically in relation to distal pancreatectomy (DP).
Chase J. Wehrle   +12 more
wiley   +1 more source

Does Medicare Benefit the Poor? New Answers to an Old Question [PDF]

open access: yes
Previous research has found that Medicare benefits flow primarily to the most economically advantaged groups and that the financial returns to Medicare are consequently higher for the rich than for the poor.
Darius Lakdawalla, Jay Bhattacharya
core  

Evaluating Cost‐Effective Strategies for Asymptomatic Microhematuria Diagnosis: A Risk‐Based Alternative to the American Urological Association Guidelines

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives The American Urological Association (AUA) guidelines recommend evaluating asymptomatic microhematuria (MH) at ≥ 3 red blood cells per high powered field (RBCs/hpf), resulting in significant costs with limited bladder cancer detections.
Krishay Sridalla   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy